NanoTemper Technologies
NanoTemper's vision is to help create a world where every disease is treatable. For them, that starts by equipping scientists with reliable tools that bring them the clarity, confidence and momentum they need to discover future therapies. With a broad offering of systems, software and consumables for evaluating binding affinities and protein stability, scientists in pharmaceutical, biotech or academic labs will find an optimized workflow, quality results and responsive customer support.
Latest Content
Infographic
Targeted Protein Degradation: A Promising Therapeutic Strategy for the Most Challenging Protein Targets
Targeted protein degradation (TPD) is getting a lot of attention as a promising modality to treat a variety of diseases from cancer to Alzheimer’s.
App Note / Case Study
Biologics Developability: Optimization of Engineered mAbs With Multi-Parameter Stability Characterization
The biologic drug development process is expensive and often leads to time and money lost on candidates that never reach the clinic. Improved developability profiles enable researchers in the early discovery stages to select candidates that have a great chance at clinical success.
Infographic
Methods To Assess the Thermal Stability of Your Therapeutic Proteins
This infographic compares four different methods to assess thermal stability and the unique value each provides.
Infographic
Stability Assessment of Biologics During Early Development Workflows
With a vast array of biologic drugs failing to make it to the clinic despite hefty investments, researchers are seeking ways to identify promising candidates earlier in the pipeline to prevent wasted resources.
How To Guide
Overcome Roadblocks to PROTAC Characterization
This guide highlights how an innovative, plate-based, and automation-ready affinity screening solution helps you overcome roadblocks in your PROTAC characterization projects.
How To Guide
Screening Biologics With nanoDSF
Choosing the wrong candidate molecule can prove costly and waste both time and resources. Therefore, it’s important to base key decisions upon the most robust thermostability and unfolding profile data.
Video
Successful Affinity-Based Lead Identification and Optimization for Challenging Targets and Ligands
Speaking at the Advances in Drug Discovery & Development 2021, NanoTemper Technologies' Amit Gupta delivered his talk on the optimization of identifying challenging targets and ligands.
Product News
NanoTemper Technologies Launches Spectral Shift
NanoTemper Technologies has announced the launch of Spectral Shift technology within their Dianthus instrument, built to handle the most challenging affinity-based screenings in drug discovery.
Advertisement
